Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medtronic (NY:MDT)

104.66 +1.95 (+1.90%)
Streaming Delayed Price Updated: 12:59 PM EST, Feb 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
News headline image
Medtronic Bets On AI Heart Care With $585 Million Deal For Partner CathWorks ↗
Medtronic plans to acquire heart imaging firm CathWorks for up to $585 million, expanding its digital heart care tools as the deal awaits U.S. regulatory approval. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race
In a move that has sent shockwaves through the healthcare sector, Boston Scientific (NYSE:BSX) has announced a definitive agreement to acquire Penumbra (NYSE:PEN) for approximately $14.5 billion. The... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Are Wall Street Analysts Predicting Medtronic Stock Will Climb or Sink?
Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects. 
Via Barchart.com
Topics ETFs Stocks
Medtronic PLC (NYSE:MDT) Shows High-Probability Technical Breakout Setup ↗
Via Chartmill
Medtronic PLC (NYSE:MDT) Stands Out as a Dependable Dividend Stock ↗
Via Chartmill
News headline image
2 AI Surgery Stocks to Buy Hand Over Fist in February ↗
Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the heart of it. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Foundation for the AI Era: Texas Instruments Commences Volume Production at $60 Billion SM1 ‘Mega-Fab’ in Sherman, Texas
In a landmark moment for the American semiconductor industry, Texas Instruments (NASDAQ: TXN) has officially commenced volume production at its state-of-the-art SM1 fab in Sherman, Texas. The facility,... 
Via TokenRing AI
Topics Artificial Intelligence Economy Supply Chain
News headline image
Boston Scientific to Acquire Penumbra for $14.5 Billion in Massive MedTech Consolidation
MARLBOROUGH, Mass. — In a move that has sent shockwaves through the medical technology landscape, Boston Scientific (NYSE: BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra... 
Via MarketMinute
News headline image
The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants
In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced on January 15, 2026, its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN)... 
Via MarketMinute
News headline image
Caterpillar, Medtronic, Transocean And A Financial Stock: CNBC&#39;s &#39;Final Trades&#39; ↗
CNBC's Halftime Report: Bryn Talkington sticking with Capital One (COF) expecting it to rise to $250 in a year. Kevin Simpson chooses Medtronic (MDT). 
Via Benzinga
News headline image
Johnson & Johnson 2026 Outlook: Chasing the $100 Billion Milestone Amidst Legal and Patent Hurdles
Following a resilient performance throughout 2025, healthcare giant Johnson & Johnson (NYSE: JNJ) has officially set its sights on a historic milestone for 2026. In its latest earnings report released... 
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
As of January 23, 2026, Johnson & Johnson (NYSE:JNJ) finds itself at a historic crossroads. After spending much of 2025 navigating the "patent cliff" of its blockbuster drug Stelara and finalizing its... 
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth
NEW BRUNSWICK, N.J. – Johnson & Johnson (NYSE: JNJ) has signaled a definitive turning point in its corporate evolution, issuing a robust 2026 financial outlook that defies the gravity of the... 
Via MarketMinute
Topics Earnings Economy Intellectual Property
News headline image
Abbott Shares Slump as Revenue Miss and Exact Sciences Acquisition Jitters Overshadow Earnings Beat
Abbott Laboratories (NYSE: ABT) saw its shares retreat by 5.8% in early trading on Thursday, January 22, 2026, following the release of its fourth-quarter financial results. Despite delivering an... 
Via MarketMinute
Topics Earnings Economy
News headline image
What to Expect From Medtronic's Next Quarterly Earnings Report
Medtronic is expected to announce its fiscal third-quarter earnings next month, and analysts project a single-digit profit drop. 
Via Barchart.com
Topics ETFs
News headline image
Want Decades of Passive Income? 2 Stocks to Buy Right Now. ↗
Their dividend streaks speak volumes. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Where Will Intuitive Surgical Be in 5 Years? ↗
The bullish case for the stock remains strong. 
Via The Motley Fool
News headline image
J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll ↗
The company is an expert in electrophysiology, but two key rivals are making a dent in its sales. 
Via Investor's Business Daily
Topics Stocks
News headline image
Why Did AVR Stock Surge Pre-Market Today? ↗
The company unveiled a $200 million dilution alongside a $90 million investment from healthcare technology heavyweight Medtronic. 
Via Stocktwits
News headline image
Nasdaq, S&P 500 Futures Rebound, All Eyes On Trump’s Davos Speech: Why TSLA, NVDA, NFLX, AVR Are On Traders' Radar Today ↗
Retail sentiment on Stocktwits on SPY and QQQ turned ‘extremely bearish’. 
Via Stocktwits
Topics Artificial Intelligence ETFs Economy
News headline image
The Titan’s Balance: Johnson & Johnson Reaches Record Highs Amidst Legal Hurdles and Med-Tech Transformation
As the healthcare industry looks toward 2026, Johnson & Johnson (NYSE: JNJ) stands at a historic crossroads, reinforcing its reputation as the ultimate bellwether for the global healthcare sector. On... 
Via MarketMinute
Topics Bankruptcy Lawsuit World Trade
News headline image
3 Reasons to Add This Medical Technology Stock to Your Portfolio in 2026 ↗
The future is looking brighter for this healthcare giant. 
Via The Motley Fool
Topics World Trade
News headline image
"Animal Spirits" Return: Morgan Stanley Signals M&A Renaissance as Healthcare and Industrials Lead Shifting Landscape
As 2026 begins, the global mergers and acquisitions (M&A) market is witnessing a profound "renaissance," driven by a confluence of stabilizing interest rates, record levels of corporate cash, and a... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition
MARLBOROUGH, MA – In a move that has sent shockwaves through the medical device sector, Boston Scientific Corporation (NYSE:BSX) announced today, January 15, 2026, a definitive agreement to acquire... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Solventum (SOLV): The 3M Spin-Off That Found Its Rhythm – A 2026 Deep-Dive Analysis
Date: January 14, 2026 Introduction Since its high-profile separation from industrial conglomerate 3M Company (NYSE: MMM) in April 2024, Solventum Corporation (NYSE: SOLV) has undergone a profound... 
Via Finterra
Topics Artificial Intelligence World Trade
News headline image
The Evolution of a Giant: A Deep Dive into the ‘New’ Johnson & Johnson (JNJ) in 2026
As of January 13, 2026, Johnson & Johnson (NYSE: JNJ) stands at a pivotal juncture in its nearly 140-year history. Once a sprawling conglomerate synonymous with baby shampoo and Band-Aids, the "New... 
Via PredictStreet
Topics Artificial Intelligence Bankruptcy Economy
News headline image
A Glimpse Into The Expert Outlook On Medtronic Through 13 Analysts ↗
 
Via Benzinga
News headline image
Medtronic (MDT) Deep-Dive: Can the MedTech Giant Outpace the Market in 2026?
Date: January 9, 2026 Introduction As the global healthcare landscape undergoes a seismic shift toward personalized medicine and AI-integrated care, Medtronic plc (NYSE: MDT) stands at a critical... 
Via PredictStreet
Topics Artificial Intelligence Economy Product Recall
News headline image
Precision Medicine and the Tubeless Revolution: An In-Depth Look at Insulet Corporation (PODD)
Today’s Date: January 9, 2026 Introduction In the rapidly evolving landscape of medical technology, few companies have managed to fundamentally reshape a multi-decade standard of care as successfully... 
Via PredictStreet
Topics Economy Product Recall World Trade
News headline image
Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026 ↗
It could be another tough year for the once-soaring drugmaker. 
Via The Motley Fool
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.